(Press-News.org) Montréal, January 28, 2013 – IRCM researchers, led by endocrinologist Dr. Rémi Rabasa-Lhoret, were the first to conduct a trial comparing a dual-hormone artificial pancreas with conventional diabetes treatment using an insulin pump and showed improved glucose levels and lower risks of hypoglycemia. Their results, published today in the Canadian Medical Association Journal (CMAJ), can have a great impact on the treatment of type 1 diabetes by accelerating the development of the external artificial pancreas.
The artificial pancreas is an automated system that simulates the normal pancreas by continuously adapting insulin delivery based on changes in glucose levels. The dual-hormone artificial pancreas tested at the IRCM controls glucose levels by automatically delivering insulin and glucagon, if necessary, based on continuous glucose monitor (CGM) readings and guided by an advanced algorithm.
"We found that the artificial pancreas improved glucose control by 15% and significantly reduced the risk of hypoglycemia as compared with conventional insulin pump therapy," explains engineer Ahmad Haidar, first author of the study and doctoral student in Dr. Rabasa-Lhoret's research unit at the IRCM and at the Department of Electrical and Computer Engineering at McGill University. "The artificial pancreas also resulted in an 8-fold reduction of the overall risk of hypoglycemia, and a 20-fold reduction of the risk of nocturnal hypoglycemia."
People living with type 1 diabetes must carefully manage their blood glucose levels to ensure they remain within a target range. Blood glucose control is the key to preventing serious long-term complications related to high glucose levels (such as blindness or kidney failure) and reduces the risk of hypoglycemia (dangerously low blood glucose that can lead to confusion, disorientation and, if severe, loss of consciousness).
"Approximately two-thirds of patients don't achieve their target range with current treatments," says Dr. Rabasa-Lhoret, Director of the Obesity, Metabolism and Diabetes research clinic at the IRCM. "The artificial pancreas could help them reach these targets and reduce the risk of hypoglycemia, which is feared by most patients and remains the most common adverse effect of insulin therapy. In fact, nocturnal hypoglycemia is the main barrier to reaching glycemic targets."
"Infusion pumps and glucose sensors are already commercially-available, but patients must frequently check the sensor and adjust the pump's output," says Mr. Haidar. "To liberate them from this sizable challenge, we needed to find a way for the sensor to talk to the pump directly. So we developed an intelligent dosing algorithm, which is the brain of the system. It can constantly recalculate insulin dosing based on changing glucose levels, in a similar way to the GPS system in a car, which recalculates directions according to traffic or an itinerary change."
The researchers' algorithm, which could eventually be integrated as software into a smart phone, receives data from the CGM, calculates the required insulin (and glucagon, if needed) and wirelessly controls the pump to automatically administer the proper doses without intervention by the patient.
"The system we tested more closely mimics a normal pancreas by secreting both insulin and glucagon," adds Dr. Laurent Legault, peadiatric endocrinologist and outgoing Director of the Insulin Pump Centre at the Montreal Children's Hospital, and co-author of the study. "While insulin lowers blood glucose levels, glucagon has the opposite effect and raises glucose levels. Glucagon can protect against hypoglycemia if a patient with diabetes miscalculates the necessary insulin dose."
"Our work is exciting because the artificial pancreas has the potential to substantially improve the management of diabetes and reduce daily frustrations for patients," concludes Dr. Rabasa-Lhoret. "We are pursuing our clinical trials to test the system for longer periods and with different age groups. It will then probably be introduced gradually to clinical practice, using insulin alone, with early generations focusing on overnight glucose controls."
###
About the study
This study was conducted with 15 adult patients with type 1 diabetes, who had been using an insulin pump for at least three months. Patients were admitted twice to the IRCM's clinical research facility and received, in random order, both treatments: the dual-hormone artificial pancreas and the conventional insulin pump therapy. During each 15-hour visit, their blood glucose levels were monitored as they exercised on a stationary bike, received an evening meal and a bedtime snack, and slept at the facility overnight.
Dr. Rabasa-Lhoret's research is funded by Diabetes Québec, the Canadian Diabetes Association, and the IRCM's J.A. De Sève Chair in clinical research. IRCM collaborators who contributed to study published in CMAJ include Maryse Dallaire, Ammar Alkhateeb, Adèle Coriati, Virginie Messier and Maude Millette. For more information on the study, please refer to the article summary published online by CMAJ: http://www.cmaj.ca/content/early/2013/01/28/cmaj.121265.abstract.
About diabetes
Type-1 diabetes is a chronic, incurable disease that occurs when the body doesn't produce enough or any insulin, leading to an excess of sugar in the blood. It occurs most often in children, adolescents or young adults. People with type-1 diabetes depend on insulin to live, either through daily injections or with a pump. Diabetes is a major cause of vision loss, kidney and cardiovascular diseases.
According to the Canadian Diabetes Association, an estimated 285 million people worldwide are affected by diabetes, approximately 10 per cent of which have type 1 diabetes. With a further 7 million people developing diabetes each year, this number is expected to hit 438 million by 2030, making it a global epidemic. Today, more than 9 million Canadians live with diabetes or prediabetes.
About Dr. Rémi Rabasa-Lhoret
Dr. Rémi Rabasa-Lhoret completed his doctoral degree (MD) with a specialization in endocrinology, metabolism and nutrition at the Université Montpellier in France. He then obtained a PhD in food sciences, and completed a postdoctoral fellowship in physiology and molecular biology. At the IRCM, Dr. Rabasa-Lhoret is Director of the Metabolic Diseases research unit, Director of the Diabetes, Metabolism and Obesity clinic, and Director of the research platform on obesity, metabolism and diabetes. He is an associate professor in the Department of Nutrition at the Université de Montréal. He is also adjunct professor in the Department of Medicine (Division of Experimental Medicine) at McGill University. Dr. Rabasa-Lhoret is a Clinical Research Scholar from the Fonds de recherche du Québec – Santé and holds the J.A. DeSève Chair in clinical research. For more information, visit www.ircm.qc.ca/rabasa.
About the IRCM
Founded in 1967, the IRCM is currently comprised of 37 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.
Artificial pancreas: The way of the future for treating type 1 diabetes
IRCM researchers take an important step in making this promising approach a reality
2013-01-29
ELSE PRESS RELEASES FROM THIS DATE:
Why are there redheads? Birds might hold the clues
2013-01-29
Red coloration—historically seen as costly in vertebrates—might represent some physiological benefit after all, according to research published in the journal Physiological and Biochemical Zoology.
Pheomelanin, which is responsible for red hair and freckles in humans and orange and chestnut coloration in other animals, is known to increase the damage to skin cells and melanoma risk when present in large amounts. Furthermore, its creation involves the consumption of glutathione, a beneficial antioxidant.
In an attempt to unearth the factors favoring the evolution of ...
AGU Journal Highlights -- Jan. 28, 2013
2013-01-29
The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL), Water Resources Research, Journal of Geophysical Research – Planets (JGR-E), Journal of Geophysical Research – Oceans (JGR-C), and Journal of Geophysical Research-Biogeosciences (JGR-G).
In this release:
1. Io's volcanism controls Jupiter's magnetospheric activity
2. Projected U.S. water use likely to increase as climate warms
3. Mercury's crust likely made of magnesium-rich basalt
4. Assessing the Great Whirl, despite all the pirates
5. Tracing ...
Bioinspired fibers change color when stretched
2013-01-29
Cambridge, Mass. – January 28, 2013 - A team of materials scientists at Harvard University and the University of Exeter, UK, have invented a new fiber that changes color when stretched. Inspired by nature, the researchers identified and replicated the unique structural elements that create the bright iridescent blue color of a tropical plant's fruit.
The multilayered fiber, described today in the journal Advanced Materials, could lend itself to the creation of smart fabrics that visibly react to heat or pressure.
"Our new fiber is based on a structure we found in nature, ...
Innovative uses of nanotechnology in food and agriculture
2013-01-29
New Rochelle, NY, January 28, 2013—The U.S. Department of Agriculture (USDA) invests nearly $10 million a year to support about 250 nanoscale science and engineering projects that could lead to revolutionary advances in agriculture and food systems. Examples of current projects in development are presented in a Special Research Section published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert Inc., publishers. The articles are available on the Industrial Biotechnology website.
In their introductory article, "Overview: Nanoscale Science and ...
Skin, soft tissue infections succumb to blue light
2013-01-29
Blue light can selectively eradicate Pseudomonas aeruginosa infections of the skin and soft tissues, while preserving the outermost layer of skin, according to a proof-of-principle study led by Michael R. Hamblin of the Massachusetts General Hospital, and the Harvard Medical School, Boston. The research is published online ahead of print in the journal Antimicrobial Agents and Chemotherapy
"Blue light is a potential non-toxic, non-antibiotic approach for treating skin and soft tissue infections, especially those caused by antibiotic resistant pathogens," says Hamblin. ...
Injecting botox into stomach does not promote weight loss
2013-01-29
Bethesda, MD (Jan. 28, 2013) – Despite conflicting data in support of the practice, some overweight Americans looking for an easy fix have turned to gastric botox injections to help them lose weight. This month in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association, researchers from the Mayo Clinic publish a definitive study finding that Botox doesn't promote weight loss.
Injecting botulinum toxin A (BTA), or Botox, into the stomach had been believed to delay emptying of the stomach, increase ...
New study shows stable fisher population in the Southern Sierra Nevada
2013-01-29
ARCATA, Calif.—After experiencing years of population decline on the West Coast, a recent study examining fisher populations found that—at least in the southern Sierra Nevada—the animal's numbers appear to be stable.
Scientists from the U.S. Forest Service's Pacific Southwest Research Station (PSW) and the Pacific Southwest Region collaborated to monitor the distribution of fishers across a 7,606-square-mile area in the southern Sierra Nevada. They used baited track-plate stations—an enclosure where the fisher leaves a sooted track print as it walks through—at 223 locations ...
Using Twitter to track the flu: A better way to screen the Tweets
2013-01-29
Sifting through social media messages has become a popular way to track when and where flu cases occur, but a key hurdle hampers the process: how to identify flu-infection tweets. Some tweets are posted by people who have been sick with the virus, while others come from folks who are merely talking about the illness. If you are tracking actual flu cases, such conversations about the flu in general can skew the results.
To address this problem, Johns Hopkins computer scientists and researchers in the university's School of Medicine have developed a new tweet-screening ...
Climate change projected to alter Indiana bat maternity range
2013-01-29
Research by US Forest Service scientists forecasts profound changes over the next 50 years in the summer range of the endangered Indiana bat. In an article published in the journal Ecology and Evolution, Forest Service Southern Research Station researchers Susan Loeb and Eric Winters discuss the findings of one of the first studies designed to forecast the responses of a temperate zone bat species to climate change.
The researchers modeled the current maternity distribution of Indiana bats and then modeled future distributions based on four different climate change scenarios. ...
New look at cell membrane reveals surprising organization
2013-01-29
LIVERMORE, CALIF. — A new way of looking at a cell's surface reveals the distribution of small molecules in the cell membrane, changing the understanding of its organization.
A novel imaging study by researchers from Lawrence Livermore National Laboratory, the University of Illinois and the National Institutes of Health revealed some unexpected relationships among molecules within cell membranes.
Their findings provide a new way of studying cell structure and ultimately its function.
Led by Mary Kraft of the University of Illinois, Peter Weber of Lawrence Livermore ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Artificial pancreas: The way of the future for treating type 1 diabetesIRCM researchers take an important step in making this promising approach a reality